The primary aim of our study is to compare the efficacy of daptomycin versus vancomycin in the treatment of bloodstream infections due to methicillin-resistant Staphylococcus aureus isolates with high vancomycin minimum inhibitory concentrations ( greater than or equal to 1.5 ug/ml ) in terms of reducing all-cause 60-day mortality .